| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.095 | 0.6 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |